H1N1 News and Research

RSS

Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.

Time-lapse imaging reveals how antimicrobial treated surfaces kill superbugs in two hours

Experts at the University of Warwick have produced microscopic footage of the potentially deadly E. coli bacteria being wiped out in just two hours on an antimicrobial treated ‘intelligent’ surface.

13 Dec 2017

Altering genetic mutation could enhance FluMist vaccine’s protective effect

Researchers at Johns Hopkins Bloomberg School of Public Health have discovered a genetic mutation in the FluMist intranasal flu vaccine that has the potential to be altered to enhance the vaccine's protective effect.

30 Nov 2017

Collaborative research identifies broadly cross-protective vaccines for H3N2 influenza

A collaborative research and development partnership between researchers at the University of Georgia and Sanofi Pasteur, the largest influenza vaccine manufacturer in the world, has resulted in the identification of a vaccine candidate that protects against multiple co-circulating strains of H3N2 influenza isolated over five seasons following testing in mouse and ferret models.

2 Nov 2017

New flu forecasting tool makes better predictions by factoring evolution of virus

Each year, public health officials monitor the spread of influenza to identify which flu strains need to go into that year's vaccines and where outbreaks will occur. But it can be difficult to predict how bad a particular flu season will be until people actually start getting sick.

25 Oct 2017

Study shows no relation between swine flu vaccination and increased risk of type 1 diabetes

There has been a fear that the swine flu vaccine, Pandemrix, would increase the risk of autoimmune diseases other than narcolepsy.

9 Oct 2017

British technology offers ultimate surface protection against Aussie flu virus

With breaking news of a more severe Aussie Flu strain heading for the UK, there is a British technology that provides the ultimate surface protection against the virus - reducing it by 99.99%!

30 Sep 2017

BioCote Silver Ion Antimicrobial Technology makes surfaces inhospitable to influenza viruses

Strike a chord please, especially in light of the BMJ's article on Tuesday about the ineffectiveness of the flu vaccine for elderly last year - just wanted to make you also aware of the ultimate surface protection against viruses like H1N1, plus all the proliferating superbugs.

11 Sep 2017

Influenza vaccination rates in children may decrease without option of nasal spray

Influenza vaccination rates in children may have decreased for the 2016-17 influenza season because of a recommendation by the Centers for Disease Control and Prevention that the nasal spray version of the vaccine not be used, according to Penn State College of Medicine researchers.

24 Aug 2017

Eggshell-like mineral layer on avian flu viruses may be cause for human infections

Avian flu can be transmitted from birds to humans; transmission among humans, however, is limited. The reason may be an eggshell-like mineral layer that the virus acquires due to the high calcium concentration in the intestines of birds.

18 Aug 2017

InDevR gets NIAID support for verification, validation studies on new potency test for influenza viruses

InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, announced support from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for verification and validation studies on a new potency test for influenza viruses with pandemic potential.

2 Aug 2017

Skin-applied microneedle patch boosts immunization to seasonal flu vaccine recipients, study finds

A boosting skin vaccination with a biodegradable microneedle patch and protein constructed from sequences of influenza virus subtypes could improve the effectiveness of conventional influenza vaccines, according to a study led by Georgia State University.

19 Jul 2017

New TSRI study could have implications for development of flu vaccines, drug therapies

Scientists at The Scripps Research Institute have shown that for the virus that causes the flu, two wrongs can sometimes make a right.

15 Jun 2017

New biosensor rapidly detects tiny concentrations of influenza A virus

Researchers have developed a new, rapid biosensor for the early detection of even tiny concentrations of the human influenza A (H1N1) virus.

30 May 2017

Study shows how influenza A hijacks human cellular machinery to replicate

Much is known about flu viruses, but little is understood about how they reproduce inside human host cells, spreading infection. Now, a research team headed by investigators from the Icahn School of Medicine at Mount Sinai is the first to identify a mechanism by which influenza A, a family of pathogens that includes the most deadly strains of flu worldwide, hijacks cellular machinery to replicate.

5 May 2017

‘Geneva signature’ evaluates safety and immunogenicity of promising anti-Ebola virus vaccine

An international team based at Geneva University Hospitals and at the University of Geneva, Switzerland, has succeeded in defining a "signature" composed of a small number of inflammatory markers that can be monitored in order to understand how a promising anti-Ebola virus vaccine stimulates the immune system.

19 Apr 2017

Scientists reveal novel drug delivery approach to fight swine flu at gene level

Scientists from Tomsk Polytechnic University together with their colleagues from St. Petersburg and London have elaborated a new approach to deliver anti-viral RNAi to target cells against H1N1 influenza virus infection.

28 Mar 2017

Study finds vaccines to be successful in preventing pandemic flu

Vaccines are successful in preventing pandemic flu and reducing the number of patients hospitalised as a result of the illness, a study led by academics at The University of Nottingham has found.

13 Mar 2017

Study shows how risk perception of flu vaccine differs between white and African American adults

Fewer than half of American adults get vaccinated despite strong recommendations from the Centers for Disease Control and Prevention and widespread availability of free and low-cost vaccines.

10 Mar 2017

High-dose flu vaccine appears to be effective at preventing post-influenza deaths among older adults

The high-dose flu vaccine appeared to be more effective at preventing post-influenza deaths among older adults than the standard-dose vaccine, at least during a more severe flu season, according to a large new study of Medicare beneficiaries published in The Journal of Infectious Diseases.

2 Mar 2017

New computer model recommends intervention strategies to mitigate pandemics

The 2016 Zika virus outbreak, along with recent outbreaks of SARS, bird flu, H1N1 and Ebola, underscore the importance of being prepared for and responding quickly to infectious diseases. Zika, in particular, poses unique challenges, since its associated birth defects and lack of preventive treatment currently threaten over 60 countries.

17 Feb 2017